BioAdvance portfolio

BioAdvance has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Website: bioadvance.com.

Type: Venture capital.

Portfolio on Recent Funding: 1.

Deals, last 12 months: 1.

Capital in their rounds: $97M.

Latest deal: Latus Bio · May 4, 2026.

About this page

It is a venture capital firm based in Conshohocken, US, founded in 2002. Its most recent investment on record is Latus Bio's $97M Series A round in May 2026, alongside DCVC Bio, Gaingels, 8VC and 6 others. That company is in Health and bio.

About BioAdvance

Firm type: Venture capital.

Headquarters: Conshohocken, US.

Founded: 2002.

Stages: Pre-Seed, Seed.

Sectors: Biotech, Digital Health, Healthtech, Longevity, Medical Devices.

Check size: $500K to $1.5M.

Leads rounds: Yes.

Portfolio companies: 65.

Exits: 1.

Rounds led: 0.

What BioAdvance invests in

Health and bio · 1 · 100%
Logistics and mobility · 1 · 100%

How BioAdvance invests

Stage	Deals	Capital in rounds
Series A	1 100%	$97M

BioAdvance portfolio companies

LLatus Bio$97MSeries A · May 2026

Company	Round with BioAdvance	Total raised	Latest raise
LLatus Bio Health and bio	May 4, 2026 Series A · $97M	$97M	May 4, 2026 Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name BioAdvance. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists BioAdvance, which is a subset of its real portfolio. API: /api/v1/investors/bioadvance (get a free API key). More: the most active VC firms and new venture capital funds.